Seizert Capital Partners LLC trimmed its holdings in shares of CRH Medical (NYSEAMERICAN:CRHM) by 20.4% in the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 170,842 shares of the company’s stock after selling 43,775 shares during the period. Seizert Capital Partners LLC owned about 0.23% of CRH Medical worth $436,000 as of its most recent SEC filing.
Other large investors have also modified their holdings of the company. Pacific Ridge Capital Partners LLC lifted its position in shares of CRH Medical by 69.9% in the 4th quarter. Pacific Ridge Capital Partners LLC now owns 2,163,944 shares of the company’s stock valued at $5,734,000 after acquiring an additional 890,300 shares in the last quarter. Ramsey Quantitative Systems purchased a new stake in shares of CRH Medical in the 4th quarter valued at approximately $128,000. Finally, Baird Financial Group Inc. purchased a new stake in shares of CRH Medical in the 4th quarter valued at approximately $301,000.
CRHM stock opened at $3.50 on Friday. CRH Medical has a 12-month low of $1.46 and a 12-month high of $6.22.
CRH Medical (NYSEAMERICAN:CRHM) last released its earnings results on Monday, April 30th. The company reported $0.02 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. The company had revenue of $24.67 million during the quarter, compared to analysts’ expectations of $21.70 million.
Separately, Zacks Investment Research upgraded shares of CRH Medical from a “hold” rating to a “buy” rating and set a $2.75 target price for the company in a research report on Tuesday, March 20th. Three equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average target price of $4.00.
CRH Medical Profile
CRH Medical Corporation provides various products and services to gastroenterologists for the treatment of gastrointestinal diseases in the United States, Canada, and internationally. It offers CRH O'Regan system, a single use, disposable, and hemorrhoid banding technology for treating various grades of hemorrhoid.
Want to see what other hedge funds are holding CRHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CRH Medical (NYSEAMERICAN:CRHM).
Receive News & Ratings for CRH Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CRH Medical and related companies with MarketBeat.com's FREE daily email newsletter.